Emerging therapies and their delivery for treating age‐related macular degeneration - Thomas - 2022 - British Journal of Pharmacology - Wiley Online Library
Emerging Pharmacological Targets for Treatment of Dry Age-related Macular Degeneration and Geographical Atrophy
New medicines targeting age-related macular degeneration, Industry news, Media Center, NovaMedica
An update on long-acting therapies in chronic sight-threatening eye diseases of the posterior segment: AMD, DMO, RVO, uveitis and glaucoma | Eye
Endpoints selection in registration clinical trials and the needs of real-world clinical practice with the example of anti-VEGF therapy in neovascular age-related macular degeneration - Astakhov - Ophthalmology Reports